BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 24774993)

  • 1. Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
    Niederkorn A; Wackernagel W; Artl M; Schwantzer G; Aigner B; Richtig E
    Acta Ophthalmol; 2014 Dec; 92(8):e696-7. PubMed ID: 24774993
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.
    Leyvraz S; Piperno-Neumann S; Suciu S; Baurain JF; Zdzienicki M; Testori A; Marshall E; Scheulen M; Jouary T; Negrier S; Vermorken JB; Kaempgen E; Durando X; Schadendorf D; Gurunath RK; Keilholz U
    Ann Oncol; 2014 Mar; 25(3):742-746. PubMed ID: 24510314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and liver-directed therapies in metastatic uveal melanoma: state-of-the-art and novel perspectives.
    Comito F; Marchese PV; Ricci AD; Tober N; Peterle C; Sperandi F; Melotti B
    Future Oncol; 2021 Nov; 17(33):4583-4606. PubMed ID: 34431316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion.
    Ben-Shabat I; Belgrano V; Ny L; Nilsson J; Lindnér P; Olofsson Bagge R
    Ann Surg Oncol; 2016 Apr; 23(4):1327-34. PubMed ID: 26628434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
    Sacco JJ; Kalirai H; Kenyani J; Figueiredo CR; Coulson JM; Coupland SE
    Future Oncol; 2018 Jun; 14(14):1335-1338. PubMed ID: 29741103
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion.
    Ludwig JM; Haubold J; Bauer S; Richly H; Siveke JT; Wimmer J; Umutlu L; Schaarschmidt BM; Theysohn JM
    Radiol Oncol; 2021 May; 55(3):347-353. PubMed ID: 34051707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality from uveal melanoma treated by enucleation --a 16-year survey in Taiwan.
    Liu YC; Tsai CC; Lee FL; Lee SM; Kao SC
    Acta Ophthalmol; 2013 Nov; 91(7):e583-4. PubMed ID: 24131706
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands.
    van der Kooij MK; Joosse A; Speetjens FM; Hospers GA; Bisschop C; de Groot JW; Koornstra R; Blank CU; Kapiteijn E
    Acta Oncol; 2017 Jan; 56(1):101-103. PubMed ID: 27911126
    [No Abstract]   [Full Text] [Related]  

  • 9. Percutaneous Isolated Hepatic Perfusion as a Treatment for Isolated Hepatic Metastases of Uveal Melanoma: Patient Outcome and Safety in a Multi-centre Study.
    Vogl TJ; Koch SA; Lotz G; Gebauer B; Willinek W; Engelke C; Brüning R; Zeile M; Wacker F; Vogel A; Radeleff B; Scholtz JE
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):864-872. PubMed ID: 28144756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study.
    Khoja L; Atenafu EG; Suciu S; Leyvraz S; Sato T; Marshall E; Keilholz U; Zimmer L; Patel SP; Piperno-Neumann S; Piulats J; Kivelä TT; Pfoehler C; Bhatia S; Huppert P; Van Iersel LBJ; De Vries IJM; Penel N; Vogl T; Cheng T; Fiorentini G; Mouriaux F; Tarhini A; Patel PM; Carvajal R; Joshua AM
    Ann Oncol; 2019 Aug; 30(8):1370-1380. PubMed ID: 31150059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study.
    Mouriaux F; Servois V; Parienti JJ; Lesimple T; Thyss A; Dutriaux C; Neidhart-Berard EM; Penel N; Delcambre C; Peyro Saint Paul L; Pham AD; Heutte N; Piperno-Neumann S; Joly F
    Br J Cancer; 2016 Jun; 115(1):20-4. PubMed ID: 27253171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient.
    Miserocchi E; Cimminiello C; Mazzola M; Russo V; Modorati GM
    Can J Ophthalmol; 2015 Feb; 50(1):e2-4. PubMed ID: 25677296
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of novel chemotherapeutic strategies for metastatic uveal melanoma.
    Fagone P; Caltabiano R; Russo A; Lupo G; Anfuso CD; Basile MS; Longo A; Nicoletti F; De Pasquale R; Libra M; Reibaldi M
    Sci Rep; 2017 Mar; 7():44564. PubMed ID: 28303962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete response to pembrolizumab after initial progress in a patient with metastatic uveal melanoma.
    Stauner CT; Drexler K; Berneburg M; Haferkamp S
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1376-1378. PubMed ID: 30299577
    [No Abstract]   [Full Text] [Related]  

  • 15. A multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapy.
    Itchins M; Ascierto PA; Menzies AM; Oatley M; Lo S; Douraghi-Zadeh D; Harrington T; Maher R; Grimaldi AM; Guminski A
    Melanoma Res; 2017 Jun; 27(3):243-250. PubMed ID: 28230715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveal melanoma: evidence for adjuvant therapy.
    Choudhary MM; Triozzi PL; Singh AD
    Int Ophthalmol Clin; 2015; 55(1):45-51. PubMed ID: 25436492
    [No Abstract]   [Full Text] [Related]  

  • 17. Metastatic disease from uveal melanoma: treatment options and future prospects.
    Carvajal RD; Schwartz GK; Tezel T; Marr B; Francis JH; Nathan PD
    Br J Ophthalmol; 2017 Jan; 101(1):38-44. PubMed ID: 27574175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors for uveal melanoma].
    Amiryan AG; Saakyan SV
    Vestn Oftalmol; 2015; 131(1):90-95. PubMed ID: 25872392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micrometastatic Dormancy in Uveal Melanoma: A Comprehensive Review of the Evidence, Mechanisms, and Implications for Future Adjuvant Therapies.
    Nichols EE; Richmond A; Daniels AB
    Int Ophthalmol Clin; 2017; 57(1):1-10. PubMed ID: 27898609
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid, Fatal Acute Right Ventricular Failure After Locoregional Cytokine Therapy for Uveal Melanoma Liver Metastases.
    Kabadi RA; Shah M; Marhefka GD; George G; Awsare B; Terai M; Sato T
    Tex Heart Inst J; 2020 Jun; 47(3):224-228. PubMed ID: 32997782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.